Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells
Journal of Innate Immunity · 12.03.2024
DOI: 10.1159/000537775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 12.03.2024. Verfasst von Anthony Altieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Airway Remodeling, Antimicrobial Cationic Peptides, Asthma, Bronchi. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR.
Abstract (Originalsprache)
Introduction
TNFα-inducible matrix metalloproteinases (MMP) play a critical role in the process of airway remodelling in respiratory inflammatory disease including asthma. The cationic host defence peptide (CHDP) LL-37 is elevated in the lungs during airway inflammation. However, the impact of LL-37 on TNFα-driven processes is not well understood. Here, we examined the effect of LL-37 on TNFα-mediated responses in human bronchial epithelial cells (HBEC).
Methods
We used a Slow Off-rate Modified Aptamer-based proteomics approach to define the HBEC proteome altered in response to TNFα. Abundance of selected protein candidates and signaling intermediates were examined using immunoassays, ELISA and Western blots, and mRNA abundance was examined by qRT-PCR.
Results
Proteomics analysis revealed that 124 proteins were significantly altered, 12 proteins were enhanced by ≥2-fold compared to unstimulated cells, in response to TNFα. MMP9 was the topmost increased protein in response to TNFα, enhanced by ~10-fold and MMP13 was increased by ~3-fold, compared to unstimulated cells. Furthermore, we demonstrated that LL-37 significantly suppressed TNFα-mediated MMP9 and MMP13 in HBEC. Mechanistic data revealed that TNFα-mediated MMP9 and MMP13 production is controlled by SRC kinase, and that LL-37 enhances related upstream negative regulators namely phosphoAKT(T308) and TNFα-mediated TNFAIP3 or A20.
Conclusions
The findings of this study suggest that LL-37 may play a role in intervening in the process of airway remodeling in chronic inflammatory respiratory disease such as asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
- Manitoba Centre for Proteomics and Systems Biology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Förderung
- CIHR
Zitieren
APA
Altieri, A., Marshall, C. L., Ramotar, P., Lloyd, D., Hemshekhar, M., Spicer, V., van der Does, A. M., & Mookherjee, N. (2024). Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells. Journal of Innate Immunity. https://doi.org/10.1159/000537775
Vancouver
Altieri A, Marshall CL, Ramotar P, Lloyd D, Hemshekhar M, Spicer V, et al. Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells. Journal of Innate Immunity. 2024. doi:10.1159/000537775
BibTeX
@article{Altieri2024,
author = {Altieri, Anthony and Marshall, Courtney Lynn and Ramotar, Padmanie and Lloyd, Dylan and Hemshekhar, Mahadevappa and Spicer, Victor and van der Does, Anne M and Mookherjee, Neeloffer},
title = {Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells},
journal = {Journal of Innate Immunity},
year = {2024},
doi = {10.1159/000537775}
}
EUVIMED